Skip to content
BALCAO · PERFUMES, COSMETICS & OTHER TOILET PREPARATIONS · SMALL CAP

Cosciens Biopharma Inc. CSCIF

11 fiscal years on record · USD · FY2025 reported · SEC filings only
$7.5M
▼ 21.8% YoY
$-10.4M
$-9.2M

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Growth

USD 7.5M
Revenue, FY2025 · full 11-year series below
Revenue $M Net income $M
FY2025 · Revenue 7.5 · Net income -10.4
10M20M-20M-40M
20152018202120242025
Compound annual growth
−19.9%
+15.5%
+30.0%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +15.5% a year over the five years to FY2025.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability

−138 cents
lost on every revenue dollar
Operating margin Net margin
FY2025 · Operating -142.5% · Net -138.1%
-2000%-4000%-6000%
201520202025
ROE
FY2025 · ROE -121.8%
-100%-200%
201520202025
Three returns, three denominators.

Each USD of equity lost 122 cents this year.

Cash & shareholders

·
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF -9.2
2.5M5.0M-15.0M-30.0M
201520202025

Total assetsUSD 21.4M
EquityUSD 3.8M
CashUSD 7.3M
Current ratio3.18×

Equity funds 18% of total assets.

The 11-year record

11 fiscal years
Every figure from documents filed with the SEC · USD

EPS, diluted, dividend per share and shares outstanding are shown without shading, and a vertical line marks the year the share count changed — the series crosses a large, unexplained change in share count, so the years on either side are not on a comparable scale.

row low → row highnegative—not applicable◌not available in our data
CSCIF, 11-year financial record
Metric 20252024202320222021202020192018201720162015
Revenue $B0.00.00.00.00.00.00.00.00.00.00.0
Operating income $B−0.0−0.0−0.00.0−0.0−0.0−0.00.0−0.0−0.0−0.0
EBITDA $B−0.0−0.0−0.00.0−0.0−0.0◌0.0−0.0−0.0−0.0
Income tax $B0.00.0−0.00.0−0.00.0−0.00.0−0.00.00.0
Net income $B−0.0−0.0−0.00.0−0.0−0.0−0.00.0−0.0−0.0−0.1
Free cash flow $B−0.0−0.0−0.00.0−0.0◌◌0.0−0.0−0.0−0.0
EPS, diluted $−3.27−5.93−1.891.86−1.82−3.11−0.350.24−1.12−2.41◌
Dividend / sh $◌◌◌◌◌◌◌◌◌◌◌
Payout % — not applicable: no dividend———————————
ROE %−121.8−89.5−15.515.1−47.6————−179.4−232.0

Slide the table for earlier years. "—" not applicable · "◌" not available in our data.

More in this sector

Other companies filing in the same sector

Provenance

Company facts, as filed

How we verify · 0 failures in 48 reconciliationsAUDITED

Reconciled in 11 of the 11 fiscal years we could check. 18 checks were skipped: the balance sheet is not tagged before 2016. Nine checks were skipped: cost of revenue is not tagged before 2016. Nine checks were skipped: EPS is not tagged before 2016.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquidityCurrency consistency0 failures
ActivityPerfumes, Cosmetics & Other Toilet Preparations
Listed onOTC market
Incorporated inoutside the United States — SEC code A6
Fiscal year endsDecember 31
Data on record since2015

Share this section

Download image